These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1069 related items for PubMed ID: 28473512

  • 1. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu's arteritis: a case-control study.
    Pan L, Du J, Li T, Liao H.
    BMJ Open; 2017 May 04; 7(4):e014451. PubMed ID: 28473512
    [Abstract] [Full Text] [Related]

  • 2. [Association between platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with disease activity in Takayasu arteritis patients].
    Li ZQ, Zheng ZH, Du WL, Pang LX, Li Y, Wu ZB, Zhu P.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Sep 24; 46(9):713-718. PubMed ID: 30293378
    [Abstract] [Full Text] [Related]

  • 3. The C-Reactive Protein/Albumin Ratio and Complete Blood Count Parameters as Indicators of Disease Activity in Patients with Takayasu Arteritis.
    Seringec Akkececi N, Yildirim Cetin G, Gogebakan H, Acipayam C.
    Med Sci Monit; 2019 Feb 22; 25():1401-1409. PubMed ID: 30792377
    [Abstract] [Full Text] [Related]

  • 4. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients.
    Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H, Hu Z, Liang Y, Yang Z, Zhong R.
    Mod Rheumatol; 2016 Feb 22; 26(3):372-6. PubMed ID: 26403379
    [Abstract] [Full Text] [Related]

  • 5. The value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as complementary diagnostic tools in the diagnosis of rheumatoid arthritis: A multicenter retrospective study.
    Jin Z, Cai G, Zhang P, Li X, Yao S, Zhuang L, Ren M, Wang Q, Yu X.
    J Clin Lab Anal; 2021 Jan 22; 35(1):e23569. PubMed ID: 32951253
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in non-dialysis patients with end-stage renal disease (ESRD).
    Li P, Xia C, Liu P, Peng Z, Huang H, Wu J, He Z.
    BMC Nephrol; 2020 Nov 25; 21(1):511. PubMed ID: 33238906
    [Abstract] [Full Text] [Related]

  • 14. Relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and disease activity in rheumatoid arthritis treated with rituximab.
    Sargin G, Senturk T, Yavasoglu I, Kose R.
    Int J Rheum Dis; 2018 Dec 25; 21(12):2122-2127. PubMed ID: 30338636
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics.
    Asahina A, Kubo N, Umezawa Y, Honda H, Yanaba K, Nakagawa H.
    J Dermatol; 2017 Oct 25; 44(10):1112-1121. PubMed ID: 28493493
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.